Trevi Therapeutics Inc (TRVI)
2.87
+0.01
(+0.35%)
USD |
NASDAQ |
Nov 14, 10:35
Trevi Therapeutics Price: 2.87 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 3.04 | 3.10 | 2.83 | 2.86 | 288172.0 |
| Nov 12, 2024 | 3.07 | 3.215 | 2.92 | 3.00 | 307466.0 |
| Nov 11, 2024 | 3.01 | 3.12 | 2.86 | 3.07 | 1.667M |
| Nov 08, 2024 | 2.88 | 2.95 | 2.81 | 2.91 | 601058.0 |
| Nov 07, 2024 | 3.09 | 3.185 | 2.80 | 2.90 | 757187.0 |
| Nov 06, 2024 | 2.99 | 3.10 | 2.97 | 3.10 | 477174.0 |
| Nov 05, 2024 | 3.02 | 3.05 | 2.86 | 3.02 | 217441.0 |
| Nov 04, 2024 | 2.99 | 3.05 | 2.954 | 3.04 | 243377.0 |
| Nov 01, 2024 | 2.99 | 3.05 | 2.875 | 3.01 | 366978.0 |
| Oct 31, 2024 | 3.04 | 3.048 | 2.94 | 2.945 | 231507.0 |
| Oct 30, 2024 | 3.05 | 3.15 | 2.985 | 3.06 | 291664.0 |
| Oct 29, 2024 | 3.15 | 3.17 | 3.04 | 3.08 | 287389.0 |
| Oct 28, 2024 | 3.16 | 3.29 | 3.15 | 3.18 | 419857.0 |
| Oct 25, 2024 | 3.12 | 3.15 | 2.97 | 3.12 | 712965.0 |
| Oct 24, 2024 | 3.22 | 3.23 | 3.08 | 3.11 | 213823.0 |
| Oct 23, 2024 | 3.21 | 3.26 | 3.13 | 3.21 | 309958.0 |
| Oct 22, 2024 | 3.40 | 3.40 | 3.08 | 3.23 | 2.609M |
| Oct 21, 2024 | 3.16 | 3.44 | 3.16 | 3.35 | 1.589M |
| Oct 18, 2024 | 3.14 | 3.14 | 3.04 | 3.12 | 290212.0 |
| Oct 17, 2024 | 3.25 | 3.33 | 3.095 | 3.12 | 317966.0 |
| Oct 16, 2024 | 3.20 | 3.29 | 3.10 | 3.20 | 460007.0 |
| Oct 15, 2024 | 3.18 | 3.31 | 3.08 | 3.18 | 153456.0 |
| Oct 14, 2024 | 3.12 | 3.22 | 3.09 | 3.18 | 310310.0 |
| Oct 11, 2024 | 3.01 | 3.18 | 2.99 | 3.12 | 208497.0 |
| Oct 10, 2024 | 2.94 | 3.12 | 2.88 | 3.00 | 304207.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.46
Minimum
Feb 23 2022
7.615
Maximum
Jul 02 2020
2.638
Average
2.57
Median
May 16 2023
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.70 |
| Palatin Technologies Inc | 1.04 |
| iBio Inc | 2.24 |
| Theriva Biologics Inc | 1.33 |
| Oragenics Inc | 0.335 |
Price Related Metrics
| Price to Book Value | 3.741 |
| Earnings Yield | -15.33% |
| Market Cap | 220.60M |